Skip to content
Catalyst

curcuminFinding

Curcumin decreases fasting blood glucose

lowersModerate evidenceFindingreplicated ×6

01 · The sentence it was drawn from

“As illustrated in significant decrease of PCOS patients’ FBG was observed after curcumin treatment comparing to that of the control group, there was a low degree of heterogeneity across the study data (WMD -3.618, 95% CI -5.165 to -2.071, P < 0.001, I2 = 20.4%).”
Quoted verbatim from Therapeutic effect and safety of curcumin in women with PCOS: A systematic review and meta-analysis.
This finding among the 111 findings on its endpoint

curcumin

Fasting blood glucose

lowers

Effect as reported

−3.618mean difference

CI −5.165 to −2.071

Who
Women with polycystic ovary syndrome (Rotterdam criteria) in 7 randomised trials; pooled curcumin or Curcuma longa water decoction against placebo, and curcumin plus metformin against metformin alone (metformin in both arms)
Dose studied
curcumin 80 to 1500 mg/day (pooled); Curcuma longa water decoction 90 ml/day in some trials

Moderate evidencePMID 36387924 · 2022

02 · The study

Study
meta-analysis
Duration
not reported

Evidence, by strength

  • strong
  • moderatethis finding
  • limited
  • very limited
  • insufficient

03 · The paper

Frontiers in endocrinology
What else it reported4 findings · 1 compound · 4 endpoints

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M6Y6D9TG7RJFBEQG333W914A